Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9325126 | Fertility and Sterility | 2005 | 5 Pages |
Abstract
In women with polycystic ovary syndrome, metformin administration, not laparoscopic ovarian drilling, reduces plasminogen activator inhibitor 1 (PAI-1) activity. The lack of a decrease in PAI-1 activity is related to a high risk for miscarriage.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stefano M.D., Francesco M.D., Angela M.D., Tiziana M.D., Achille M.D., Fulvio M.D.,